Neurocognitive and Behavioral Issues in PKU

Similar documents
NEUROCOGNITIVE, OUTCOMES IN PKU: IT S TIME TO RAISE THE BAR

Molecular Genetics and Metabolism

2015 PKU Patient Survey Results. National PKU Alliance PO Box 501, Tomahawk, WI

Neuropsychology of Attention Deficit Hyperactivity Disorder (ADHD)

PKU, KUVAN, and You PKU treatment and support for adults and young adults

1 Cognitive, Psychological and Behavioral Assessment Based Evidence

ESPEN Congress Madrid 2018

Chapter 1: What is PKU?

Supplementary Online Content

SAMPLE PSYCHOEDUCATIONAL REPORT. Atlanta Pediatric Psychology Associates 3580 Habersham at Northlake Tucker, Georgia (770)

Carmen Inoa Vazquez, Ph.D., ABPP Clinical Professor NYU School of Medicine Lead Litigation Conference Philadelphia May 19, 2009 Presentation

Committee Approval Date: August 15, 2014 Next Review Date: September 2015

Neuropsychology of Attention Deficit Hyperactivity Disorder (ADHD)

NEUROPSYCHOLOGICAL ASSESSMENT S A R A H R A S K I N, P H D, A B P P S A R A H B U L L A R D, P H D, A B P P

PKU. and the brain. How PKU affects the brain. Is there a relationship between PKU and ADHD? Assessments in metabolic clinics.

4. FJ van Spronsen, GM Enns. Future treatment strategies in phenylketonuria. Molecular Genetics and Metabolism 99 (2010): S90 S95.

Pegvaliase for the treatment of hyperphenylalaninaemia in adults with phenylketonuria first line

Best Practices for Optimal Management of Patients With Phenylketonuria Across the Lifespan: How Should the Latest Evidence Inform Our Practice?

NeuroTracker Published Studies & Research

SUPPORTING COGNITIVE DEVELOPMENT IN HEART CHILDREN

Improving the Methodology for Assessing Mild Cognitive Impairment Across the Lifespan

From: What s the problem? Pathway to Empowerment. Objectives 12/8/2015

PKU, KUVAN, and Your Child Making smart choices for PKU treatment

Snohomish Middle School 321 West B Street Snohomish, Wa Initial Evaluation

Neuropsychology and Metabolic Conditions: The Neurocognitive Profile of FOD/OAA and the benefits of neuropsychological assessment

K = What do we already know (or think we know)? W = What do we want to learn or what we wonder about?

Using Neuropsychological Experts. Elizabeth L. Leonard, PhD

Tests/subtests that may capture this skill a,b. How it might look in school or in the home c Response inhibition

An empirical analysis of the BASC Frontal Lobe/Executive Control scale with a clinical sample

Group education for children with phenylketonuria

Assessing the Neurocognitive Effects of Brain Injury: Why Schools Fail Lead Poisoned Children

This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and

Topics to Discuss. The Skeptic. The Human Brain. Right Brain! Left Brain! Hey, What About the Front Brain? Executive Functioning in the 21st Century

W E N D Y H A R T I N G E R

NIH Public Access Author Manuscript Curr Dir Psychol Sci. Author manuscript; available in PMC 2010 February 1.

Understanding Students with Attention-Deficit/ Hyperactivity Disorder

The What, Why and How of Large Neutral Amino Acids

CLINICAL PRIORITIES ADVISORY GROUP 06 and 07 November 2018

Neurodevelopmental areas of assessment: criteria for severe impairment

What s Wrong With My Client: Understanding Psychological Testing in Order to Work Effectively With Your Expert

Supplementary appendix

Managing ADHD. Strategies and Modifications for Counselors and Teachers

INTRODUCTION TO EDUCATIONAL NEUROSCIENCE

University of Groningen. A lifetime with Phenylketonuria Jahja, Rianne

The Context and Purpose of Executive Function Assessments: Beyond the Tripartite Model

GENOTYPE-PHENOTYPE CORRELATIONS IN GALACTOSEMIA COMPLICATIONS COMPLICATIONS COMPLICATIONS LONG-TERM CHRONIC COMPLICATIONS WITH NO CLEAR CAUSE

Correlation of Age-Specific Phenylalanine Levels on Intellectual Outcome in Patients with Phenylketonuria

Detecting neurocognitive impairment in HIV-infected youth: Are we focusing on the wrong factors?

Simons VIP Phenotyping: What we ve learned so far. Ellen Hanson, Ph.D. and Raphael Bernier, Ph.D. Family Meeting Summer, 2015

Kelsey DeGrave, M.S., M.A. Midwestern University, Glendale College of Health Sciences, Clinical Psychology Program

Neuropsychology in Spina Bifida. Dr Ellen Northcott Clinical Neuropsychologist Kids Rehab, CHW

PRACTICE PARAMETERS FOR THE ASSESSMENT AND TREATMENT OF CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER

Adolescent Mental Health. Vicky Ward, MA Sociology Manager of Prevention Services

Revision Log. See Important Reminder at the end of this policy for important regulatory and legal information.

Developmental trajectories in cognitive development in 22q11 deletion syndrome

The Role of Executive Functions in Attention Deficit Hyperactivity Disorder and Learning Disabilities

Merck KGaA, Darmstadt, Germany, Receives EU-Approval to Extend Kuvan Use to Children with PKU Below 4 Years of Age

IMPORTANT: Upcoming Test

Hocus, Pocus, Focus! Springfield Park Elementary Christina Vitek, School Psychologist

Not intended for UK based media. Merck Announces Detailed 26-Week Results from Phase IIIb Study with Kuvan in children with PKU below 4 years of age

Ronette Goodwin, Ph.D. Forensic and Psychological Experts, Inc Crenshaw Blvd. #179 Torrance, CA (866)

Amal Alamri. Phenylketonuria

Does Physical Exercise Contribute to Academic Performance among Adolescents with Autism Spectrum Disorder?

Improving Attention and Learning in Children & Adolescents: The Role of Working Memory

Difference between ADHD and Executive Functioning. Dr. Josette Abdalla

Molecular Genetics and Metabolism

Semester Summary of Practicum Hours: Documentation Form (Updated: November 2017)

AP PSYCH Unit 11.2 Assessing Intelligence

Comprehensive Psychological Services Raymond H. McCaffrey, Ph.D th Ave. S.W. Norman, Oklahoma Phone , Fax

Assessment for Students who are Deaf or Hard of Hearing

A systematic review of cognitive functioning in early treated adults with phenylketonuria

BOROUGH OF MANHATTAN COMMUNITY COLLEGE City University of New York Department of Social Sciences

More Accomplishment! Less Struggle. Bridging the Gaps in Executive Function to Empower our Children with ADHD to Succeed

Clinical Commissioning Policy: Sapropterin for Phenylketonuria (all ages) NHS England Reference: P

MINDFULNESS & EDUCATION. Davis Behavioral Health

National MFT Exam Study System

Marianne Løvstad, PhD, Clinical neuropsychologist; Sunnaas rehabilitation Hospital, Ass. Prof., Dept. of psychology, University of Oslo

7/10/13. Middle and Late Childhood (~6 10/11) Cognitive and physical development. Practice Question. Questions? Material? Course business?

Accessibility and Disability Service. A Guide to Services for Students with

ADHD: MORE THAN ATTENTION PROBLEM JULIE STECK, PH.D., HSPP CRG/CHILDREN S RESOURCE GROUP

Genetic Counselors role in maternal PKU: Patient and Genetic Counselor perspectives. Master s Thesis. Presented to

written by Harvard Medical School ADHD Attention Deficit Hyperactivity Disorder

9/29/2011 TRENDS IN MENTAL DISORDERS. Trends in Child & Adolescent Mental Health: What to look for and what to do about it. Autism Spectrum Disorders

Neuropsychological Assessment: Optimizing Protective Factors through Psychosocial, Behavioral, and Educational Recommendations

Working memory: A cognitive system that supports learning?

Trends in Child & Adolescent Mental Health: What to look for and what to do about it.

TOMPKINS CORTLAND COMMUNITY COLLEGE (TC3) Jed H. Weitzen, Ph.D.

CRITICALLY APPRAISED PAPER (CAP)

Finnish practices: Cognitive assessment and interventions

Focus! Helping the Distracted/Hyperactive Child in Your Classroom. Muriel K. Rand The Positive Classroom

Neuropsychological Development in Children with Early and. Continuously Treated Phenylketonuria: Association with. Biochemical Markers

Gender Sensitive Factors in Girls Delinquency

IMPORTANT: Upcoming Test

SUPPORT INFORMATION ADVOCACY

Eric Ward Bravo, Psy.D. 707 Conservation Lane Suite 300

Chapter Three BRIDGE TO THE PSYCHOPATHOLOGIES

Executive Dysfunction after Moderate and Severe Pediatric Traumatic Brain Injury

Pediatric Traumatic Brain Injury. Seth Warschausky, PhD Department of Physical Medicine and Rehabilitation University of Michigan

Transcription:

Neurocognitive and Behavioral Issues in PKU Susan Waisbren, PhD Associate Professor of Psychology Harvard Medical School Children s Hospital Boston Boston, Massachusetts Content developed in conjunction with Desiree A. White, PhD, Associate Professor, Department of Psychology, Washington University, St. Louis, Missouri

Faculty Disclosure It is the policy of The France Foundation to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, and staff participating in this activity will disclose any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. The France Foundation has identified and resolved any and all faculty conflicts of interest prior to the release of this activity. Susan Waisbren, PhD, has received research grants/support from and served as a consultant for BioMarin. Desiree White, PhD, has received research grants/support from, served as a consultant for, and received honoraria from BioMarin.

Educational Learning Objective Describe the impact of elevated Phe on longterm patient outcomes

KEY POINTS 1. High Phenylalanine (Phe) levels harm the brain 2. Traditional therapies do not completely protect individuals with PKU 3. Neuropsychological follow-up is important in identifying deficits associated with even well-treated PKU

KEY POINT #1 High Phenylalanine (Phe) levels harm the brain. 1. Evidence 2. Dopamine hypothesis 3. White matter hypothesis

Blood Phe and IQ Are Correlated in Individuals With PKU Observation period Critical period (0 12 years old) Lifetime (all ages) Correlation between blood Phe and IQ Lifetime IQ loss for each 100 µmol/l (1.6 mg/dl) increase in blood Phe (IQ points) r = -0.35* 1.3 3.1 r = -0.34* 1.9 4.1 * P < 0.05 Waisbren SE, et al. Mol Genet Metab. 2007;92:63-70.

Outcomes for Adults with PKU Are Worse if Discontinue Diet Outcome Discontinued Diet Continued Diet Medical Problems 2.4 ± 1.8 0.9 ± 1.4 College Degree 32% 78% Socioeconomic Class I or II* 19% 44% *Two highest socioeconomic classes in the Hollingshed classification system Koch R, et al. J Inherit Metab. 2002;25:333-346.

Figure adapted from Youdim MB, et al. Nature Rev Neurosci. 2006;7:295-309. Image from http://nobelprize.org/nobel_prizes/medicine/laureates/2000/press.html. Accessed Oct ober 2010. Prefrontal Cortex Is Sensitive to Reductions in Dopamine Blood Brain Barrier Dopamine Pathways Periphery (mostly liver) Brain PAH = phenylalanine hydroxylase BH4 = tetrahydrobiopterin TH = tyrosine hydroxylase AADC = aromatic amino acid decarboxylase

White Matter Image from: RC McKinstry Washington University Mallinckrodt Institute of Radiology Myelin insulates axons to increase speed of neural signal transmission Image from: http://kvhs.nbed.nb.ca/gallant/biology/schwann_myelin.html. Accessed October 2010.

KEY POINT #2 Traditional therapies do not completely protect individuals with PKU. 1. Adherence 2. Cognitive abilities 3. School achievement 4. Executive functioning 5. Processing speed 6. Emotional issues

% Above Recommended Range. Adherence to Diet Is Difficult ~1 in 3 children less than 10 years of age have blood Phe above recommended range Noncompliance increases in adolescence 90 80 70 79% 60 50 50% 40 30 28% 27% 20 10 0 0 4 years 5 9 years 10 14 years 15 19 years Adapted from Table 2 of Walter JH, et al. Lancet. 2002;360:55-57.

Wechsler Intelligence Scale IQ. Wechsler Intelligence Scale IQ. Children with PKU on Diet Are at Risk for Lowered IQ P < 0.001 130 P < 0.0001 120 120 Gassio et al 2005 110 Koch et al 1984 110 100 100 90 90 80 80 70 Peers PKU 70 Siblings PKU Blood Phe and IQ are correlated Waisbren et al 2007 Variability in Blood Phe may be important Anastasoaie et al 2008 Gassio R, et al. Pediatr Neurol. 2005;33:267 271. Waisbren SE, et al. Mol Genet Metab. 2007;92:63-70. Koch R, et al. J Inherit Metab Dis. 1984;7:86-90. Anastasoaie V, et al. Mol Genet Metab. 2008;95:17-20.

% Students With School Problems. Children with PKU on Diet Present More School Problems than Unaffected Peers 60 50 P < 0.03 50% Total school problems Required special tutoring Repeated classes 40 39% 30 20 10 12% 24% 19% 5% 0 PKU Students Unaffected Peers Gassio R, et al. Pediatr Neurol. 2005;33:267-271.

Executive Functioning Deficits We don t know if he s missing or just lost under all that paper! Planning Organization Working memory Initiation Inhibition of usual response Cognitive flexibility

Summary Memory Score Executive Deficits Across the Lifespan that May Worsen with Age 8 7 6 5 4 Control PKU 3 2 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Age (years) White et al 2001 Diamond A, et al. Monogr Soc Res Child Dev. 1997;62:1-208. Huijbregts SC, et al. Neuropsychology. 2003:17,369 379. Araujo GC, et al. Neuropsychology. 2009;23:130-134. Channon S, et al. Neuropsychology. 2004;4:613-620. VanZutphen KH, et al. Clin Genet. 2007;72:13-18. White DA, et al. J Int Neuropsychol Soc. 2002;8:1-11. White DA, et al. Neuropsychology. 2001;15(2):221-229.

Executive Deficits Make Diet Adherence Difficult Planning diet Remembering Phe intake for records Remembering to take formula Inhibiting impulse to eat foods not allowed on diet Maintaining medical food supplies Monitoring blood Phe and making appropriate adjustments in intake

Test Score. Time to Rapid Retrival. Speed of Processing Is Reduced in Children with PKU Control PKU 14 12 10 8 6 P < 0.01 P < 0.01 80 70 60 50 40 30 P < 0.01 4 20 2 10 0 Symbol Search Coding 0 Contingency Naming Anderson PJ, et al. Dev Neuropsychol. 2007;32(2):645-668.

% Patients Reporting Symptom. Adults with PKU Demonstrate Increase in Psychiatric Symptoms 40 37 Control PKU 35 30 31 25 20 15 10 5 0 19% Depressed Mood 16% Phobias 14 14 5% 5% Generalized Anxiety Psychiatric Symptoms Hypochondriac Worries 1% 6 Anxiety at Work *P < 0.05 compared with 18-year-old controls Adapted from Table 3 of Pietz J, et al. Pediatrics. 1997;99:345-350.

KEY POINT #3 Neuropsychological follow-up is important in identifying subtle deficits associated with even well treated PKU. 1. Case study 2. Screening by non-psychologists 3. The Genetics and Metabolism Psychology Network

Case Study: A.D. History Male with PKU, now age 11 years Newborn screening level 30 mg/dl Over-treated until 17 months Failure to thrive and mild microcephaly Poor metabolic control from ages 2 4 years, until g-tube placed for intake of formula Levels varied until age 10 years 3.6 16.9 mg/dl ADHD medication required IQ = 81 (100 is average)

Case Study Recent and Current Began treatment with sapropterin at age 10 Blood Phe steady at 5.4 mg/dl No longer needs ADHD medication Height 5 th percentile; weight 2 nd percentile IQ = 105 (Increase of 24 points)

Case Study Current 11-year-old boy in 4 th grade Continues with g-tube Eczema and bedwetting Receives occupational therapy Has attention problems and requires one-on-one aide in classroom Kind, imaginative, eager to please Enjoys socializing, video games, sports

Assessment Observations Polite, cheerful, talkative Concentrated fairly well, but hummed as worked Enjoyed relating facts about spiders Told far-fetched stories about school and home, stating these capture interest of other children Did not appear to believe stories, but rather to intentionally elaborate

WASI Score 120 Intellectual Performance Wechsler Abbreviated Scale of Intelligence (WASI) 100 80 60 Average AD 40 20 0 Vocabulary Matrix Reasoning Full Scale IQ

Executive Functioning Example List Carrot Taxi Elephant Car Airplane Lettuce Cat Potato Butterfly Spinach Boat Tiger Scooter Squash Parrot California Verbal Learning Test Trial 1: 4 words Trial 5: 9 words (Used categories) Previous Year Trial 1: 3 words Trial 5: 5 words

Processing Speed Example of a Symbol Search Task ø ƒ YES YES NO NO

WISC-IV Subtest Score Wechsler Intelligence Scale for 12 Children 10 8 Average AD 6 4 2 0 Symbol Search Coding

Academic Achievement (WIAT) Reading Recognition: 5 th grade level Reading increased 1 grade in last year Numerical Operations: 3 rd grade level Careless errors, could not borrow or carry, did not attempt adding long columns of numbers Math increased 1/2 grade in last year WIAT: Wechsler Individual Achievement Test

Visual Motor Integration Berry Visual Motor Integration Test (VMI): Standard Score = 70 (100 is average) Drew with confidence, but poor organization so details misplaced. Same score as last year.

Recommendations Continue with extra help and occupational therapy Teach compensatory strategies in arithmetic Psychological counseling Behavioral therapy for weaning from g-tube Medical evaluation for eczema and bedwetting Re-evaluation in one year

Screening Tests That Can Be Administered by Non-Psychologists PSYCHOLOGICAL REALM TEST Adaptive Functioning Adaptive Behavior Assessment System (ABAS-II) Behavior Executive Functioning Behavior Assessment System for Children (BASC-II) Behavior Rating Inventory of Executive Function (BRIEF)

Abbreviations & Sources ABAS-II: Adaptive Behavior Assessment System- Second Edition (Harrison, Oakland 2003) BRIEF: Behavior Rating Inventory of Executive Function (Gioia, Isquith, Guy, Kenworthy, 2000) BASC-II: Behavior Assessment System for Children- Second Edition (Reynolds, Kamphus, 2004) BAI: Beck Anxiety Inventory (Beck, Steer,1993) BDI-II: Beck Depression Inventory-Second Edition (Beck, Steer, Brown,1996)

Genetics and Metabolism Psychology Network

KEY POINTS 1. High Phenylalanine (Phe) levels harm the brain 2. Traditional therapies do not completely protect individuals with PKU 3. Neuropsychological follow-up is important in identifying deficits associated with even well-treated PKU